Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
4 trials
Recent
Start date
Enrollment
Phase 2
×
Ado-Trastuzumab Emtansine
×
Gastrointestinal
×
Clear all
Filters
3
NCT04591431
2023-10-03
ROME
Fondazione per la Medicina Personalizzata
Phase 2
Unknown
400 enrolled
NCT02999672
2019-08-28
KAMELEON
Hoffmann-La Roche
Phase 2
Completed
20 enrolled
14 charts
NCT03418558
2018-10-31
RESCUE
Fondazione del Piemonte per l'Oncologia
Phase 2
Unknown
13 enrolled
NCT03225937
2018-10-30
HERACLES
Fondazione del Piemonte per l'Oncologia
Phase 2
Unknown
54 enrolled